首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Alzheimers & dementia-translational research & clinical interventions

缩写:

ISSN:N/A

e-ISSN:2352-8737

IF/分区:6.8/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1029
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Belinda M Brown,Stephanie R Rainey-Smith,Natalie Castalanelli et al. Belinda M Brown et al.
Introduction: Inconsistent results from previous studies of exercise and cognitive function suggest that rigorously designed randomized controlled trials are urgently needed. Here, we describe the design of the Intense Ph...
Ryan M Carnahan,Grant D Brown,Elena M Letuchy et al. Ryan M Carnahan et al.
Introduction: Antipsychotics are used for managing behavioral and psychological symptoms of dementia (BPSD) but have risks. Anticholinergics can worsen outcomes in dementia. The Improving Antipsychotic Appropriateness in ...
Ying-Hwey Nai,Miho Shidahara,Chie Seki et al. Ying-Hwey Nai et al.
Introduction: To facilitate radiotracers' development, a screening methodology using a biomathematical model and clinical usefulness index (CUI) was proposed to evaluate radiotracers' diagnostic capabilities. ...
Ann M Hake,Penny A Dacks,Stephen P Arnerić;CAMD ICF working group Ann M Hake
Introduction: Informed consent forms that restrict the distribution of data and samples have been an impediment to advancing Alzheimer's disease (AD) understandings and treatments. The Coalition Against Major Disease publ...
Diane M Jacobs,M Colin Ard,David P Salmon et al. Diane M Jacobs et al.
Introduction: Practice effects (PEs) present a potential confound in clinical trials with cognitive outcomes. A single-blind placebo run-in design, with repeated cognitive outcome assessments before randomization to treat...
Akira Nishimura,Hidenori Nonomura,Shingo Tanaka et al. Akira Nishimura et al.
Introduction: Dementia is one of the major health threats to our aging society, and Alzheimer's disease (AD) is the leading cause. In Japan, ∼15% of the elderly population has dementia. The apolipoprotein E (APOE) genoty...
Daniela Bertens,Betty M Tijms,Lisa Vermunt et al. Daniela Bertens et al.
Introduction: We investigated the influence of different inclusion criteria for preclinical and prodromal Alzheimer's disease (AD) on changes in biomarkers and cognitive markers and on trial sample size estimates. ...
Sharon J Sha,Zachary A Miller,Sang-Won Min et al. Sharon J Sha et al.
Introduction: Frontotemporal lobar degeneration-causing mutations in the progranulin (GRN) gene reduce progranulin protein (PGRN) levels, suggesting that restoring PGRN in mutation carriers may be therapeutic. Nimodipine,...
Grazyna Pomorska,Judith K Ockene Grazyna Pomorska
The goal of this article was to look at the problem of Alzheimer's disease (AD) through the lens of a socioecological resilience-thinking framework to help expand our view of the prevention and treatment of AD. This serious and complex publ...
Junli Zhen,Yanjing Qian,Xiechuan Weng et al. Junli Zhen et al.
Introduction: The abnormal amyloid β (Aβ) accumulation and Aβ-related neural network dysfunction are considered central to the pathogenesis of Alzheimer's disease (AD) at the early stage. Deep-brain reachable low field...